Statistics for Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
Total visits
| views | |
|---|---|
| Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study | 18 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| fendo-13-899616.pdf | 16 |
Top country views
| views | |
|---|---|
| United States | 13 |
| India | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 9 |
| Ann Arbor | 1 |
| Lake Mary | 1 |
| Pune | 1 |